Exponent, Inc. (NASDAQ:EXPO – Get Free Report) insider Eric Guyer sold 1,846 shares of the business’s stock in a transaction that occurred on Monday, May 20th. The stock was sold at an average price of $95.18, for a total transaction of $175,702.28. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Eric Guyer also recently made the following trade(s):
- On Tuesday, April 30th, Eric Guyer sold 1,650 shares of Exponent stock. The stock was sold at an average price of $92.58, for a total transaction of $152,757.00.
Exponent Price Performance
Shares of EXPO opened at $95.94 on Thursday. The company has a market capitalization of $4.86 billion, a PE ratio of 48.45 and a beta of 0.64. Exponent, Inc. has a one year low of $64.61 and a one year high of $102.72. The company’s fifty day moving average price is $85.41 and its 200 day moving average price is $83.40.
Exponent Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 21st. Stockholders of record on Friday, June 7th will be paid a $0.28 dividend. The ex-dividend date is Friday, June 7th. This represents a $1.12 annualized dividend and a dividend yield of 1.17%. Exponent’s payout ratio is 56.57%.
Hedge Funds Weigh In On Exponent
A number of institutional investors and hedge funds have recently bought and sold shares of EXPO. Operose Advisors LLC acquired a new stake in Exponent in the 3rd quarter worth $39,000. Benjamin F. Edwards & Company Inc. lifted its stake in shares of Exponent by 866.0% in the first quarter. Benjamin F. Edwards & Company Inc. now owns 512 shares of the business services provider’s stock valued at $42,000 after buying an additional 459 shares during the period. Janiczek Wealth Management LLC lifted its stake in shares of Exponent by 293.7% in the first quarter. Janiczek Wealth Management LLC now owns 626 shares of the business services provider’s stock valued at $52,000 after buying an additional 467 shares during the period. Principal Securities Inc. acquired a new stake in Exponent during the fourth quarter worth about $69,000. Finally, YHB Investment Advisors Inc. bought a new position in Exponent during the first quarter valued at about $75,000. Institutional investors own 92.37% of the company’s stock.
Analysts Set New Price Targets
EXPO has been the subject of a number of analyst reports. Truist Financial boosted their price target on Exponent from $95.00 to $100.00 and gave the stock a “buy” rating in a research report on Monday, April 29th. StockNews.com upgraded Exponent from a “sell” rating to a “hold” rating in a report on Monday, March 4th.
Get Our Latest Stock Report on Exponent
About Exponent
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Articles
- Five stocks we like better than Exponent
- Stock Market Sectors: What Are They and How Many Are There?
- TJX Companies Can Hit New Highs; Double-Digit Upside to Follow
- Basic Materials Stocks Investing
- A Hidden Gem Retailer With 20% Upside
- Golden Cross Stocks: Pattern, Examples and Charts
- Zoom Stock’s Earnings Volatility Picked Up a Lot of Buyers
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.